-+ 0.00%
-+ 0.00%
-+ 0.00%

BriaCell To Present Preclinical Data On Next-Gen Cancer Vaccine Platform At SITC 2025

Benzinga·11/04/2025 12:36:09
Listen to the news

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ))) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce that the Company will be showing evidence of strong immune system engagement inducing potent anti-cancer cell activity of its next generation Bria-OTS+ platform in preclinical models at a poster presentation at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, to be held November 7-9, 2025, in National Harbor, MD. The details are listed below.

Title: Redefining Cancer Vaccines: Bria-OTS+ Integrates Trained Innate Immunity and Adaptive Memory to Overcome Immune Resistance

Abstract Number: 353

Location: Prince George ABC Exhibit Halls, Gaylord National Resort and Convention Center

Date: Friday, November 7, 2025

Time: 12:15-1:45 PM, and 5:35-7 PM ET